Kukje Pharma, Samil Pharmaceutical & Wooridul Pharmaceutical in R&D expense growth rate in 1st quarter
When it comes to this 1st quarter’s average R&D expenses growth rate compared to the same quarter of the last year, KOSPI listed pharmaceutical companies had an increase, but pharmaceutical companies in the KOSDAQ had a decrease. Both of the groups recorded about 8% in the R&D expense ratio to sa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
